CHIEF OPERATING OFFICER · Kiniksa Pharmaceuticals International, plc · Class A Ordinary Share
Side
F
Value
$38K
Shares
774
Price
$48.94
Executed
Apr 7, 2026
Disclosed
Apr 8, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 7 executedApr 8, 2026 disclosed
KNSA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+5 / 25
$38K reported value · 6.0% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Moat Ross filed this Form 4 reporting a tax withholding of KNSA on Apr 7, 2026. It became public on Apr 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
